Saliva, Swallowing, and Breathing: The Ultimate Challenge of Amyotrophic Lateral Sclerosis

References

1. 1.↵
   1. Stambler N,
   2. Charatan M,
   3. Cedarbaum JM

   . Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50(1):66-72.

   OpenUrlPubMed
2. 2.↵
   1. Morgan S,
   2. Orrell RW

   . Pathogenesis of amyotrophic lateral sclerosis. Br Med Bull 2016;119(1):87-98.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Miller RG,
   2. Mitchell JD,
   3. Moore DH

   . Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev 2012(;3):CD001447.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Aboussouan LS,
   2. Khan SU,
   3. Meeker DP,
   4. Stelmach K,
   5. Mitsumoto H

   . Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997;127(6):450-453.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Lyall RA,
   2. Donaldson N,
   3. Fleming T,
   4. Wood C,
   5. Newsom DI,
   6. Polkey MI,
   7. Moxham J

   . A prospective study of quality of life in ALS patients treated with noninvasive ventilation. Neurology 2001;57(1):153-156.

   OpenUrlPubMed
6. 6.↵
   1. Bourke SC,
   2. Tomlinson M,
   3. Williams TL,
   4. Bullock RE,
   5. Shaw PJ,
   6. Gibson GJ

   . Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol 2006;5(2):140-147.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Cazzolli PA,
   2. Brooks RB,
   3. Nakayama Y,
   4. Lewarski JS,
   5. McKim DA,
   6. Holt SL,
   7. Chatburn RL

   . The oral secretion scale and prognostic factors for survival in subjects with amyotrophic lateral sclerosis. Respir Care 2020;65(8):1063-1076.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Cedarbaum JM,
   2. Stambler N,
   3. Malta E,
   4. Fuller C,
   5. Hilt D,
   6. Thurmond B,
   7. Nakanishi A

   . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169(1-2):13-21.

   OpenUrlCrossRefPubMedWeb of Science